milrinone has been researched along with Ischemia in 6 studies
Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the efficacy of zinc oxide nanoparticles (ZnO-NPs) and/or milrinone (MIL) on renal ischemia/reperfusion injury (I/RI) in rats and their possible underlying mechanisms." | 8.31 | The combined effect of zinc oxide nanoparticles and milrinone on acute renal ischemia/reperfusion injury in rats: Potential underlying mechanisms. ( Abu-Heakal, N; Ali, IS; Awadin, W; Barakat, N; Elshal, MF; Embaby, EM; Marghani, BH; Saleh, RM, 2023) |
| " The phosphodiesterase-3 inhibitor, milrinone, has been reported to attenuate hepatic ischemia-reperfusion injury (IRI)." | 7.96 | Pretreatment with a Phosphodiesterase-3 Inhibitor, Milrinone, Reduces Hepatic Ischemia-Reperfusion Injury, Minimizing Pericentral Zone-Based Liver and Small Intestinal Injury in Rats. ( Fushida, S; Gabata, R; Hayashi, H; Makino, I; Miyashita, T; Nakanuma, S; Ohbatake, Y; Ohta, T; Okazaki, M; Sakai, S; Shinbashi, H; Tajima, H; Takamura, H, 2020) |
| "Our results confirmed that milrinone nebulization during warm ischemia maintained lung tissue adenosine triphosphate levels." | 7.74 | Potential for pulmonary protection by nebulized milrinone during warm ischemia. ( Aoyama, A; Bando, T; Chen, F; Fujinaga, T; Okamoto, T; Zhang, J, 2008) |
| "To investigate the efficacy of zinc oxide nanoparticles (ZnO-NPs) and/or milrinone (MIL) on renal ischemia/reperfusion injury (I/RI) in rats and their possible underlying mechanisms." | 4.31 | The combined effect of zinc oxide nanoparticles and milrinone on acute renal ischemia/reperfusion injury in rats: Potential underlying mechanisms. ( Abu-Heakal, N; Ali, IS; Awadin, W; Barakat, N; Elshal, MF; Embaby, EM; Marghani, BH; Saleh, RM, 2023) |
| " The phosphodiesterase-3 inhibitor, milrinone, has been reported to attenuate hepatic ischemia-reperfusion injury (IRI)." | 3.96 | Pretreatment with a Phosphodiesterase-3 Inhibitor, Milrinone, Reduces Hepatic Ischemia-Reperfusion Injury, Minimizing Pericentral Zone-Based Liver and Small Intestinal Injury in Rats. ( Fushida, S; Gabata, R; Hayashi, H; Makino, I; Miyashita, T; Nakanuma, S; Ohbatake, Y; Ohta, T; Okazaki, M; Sakai, S; Shinbashi, H; Tajima, H; Takamura, H, 2020) |
| "Our results confirmed that milrinone nebulization during warm ischemia maintained lung tissue adenosine triphosphate levels." | 3.74 | Potential for pulmonary protection by nebulized milrinone during warm ischemia. ( Aoyama, A; Bando, T; Chen, F; Fujinaga, T; Okamoto, T; Zhang, J, 2008) |
| "Milrinone is a phosphodiesterase-3 inhibitor used for its vasodilatory effects on the systemic and pulmonary vasculature." | 1.51 | A novel role for milrinone in neonatal acute limb ischaemia: successful conservative treatment of thrombotic arterial occlusion without thrombolysis. ( Belik, J; Boyd, S; Shah, V, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Embaby, EM | 1 |
| Saleh, RM | 1 |
| Marghani, BH | 1 |
| Barakat, N | 1 |
| Awadin, W | 1 |
| Elshal, MF | 1 |
| Ali, IS | 1 |
| Abu-Heakal, N | 1 |
| Kurup, V | 1 |
| Simpson, RS | 1 |
| Boyd, S | 1 |
| Shah, V | 1 |
| Belik, J | 1 |
| Nakanuma, S | 1 |
| Tajima, H | 1 |
| Takamura, H | 1 |
| Sakai, S | 1 |
| Gabata, R | 1 |
| Okazaki, M | 1 |
| Shinbashi, H | 1 |
| Ohbatake, Y | 1 |
| Makino, I | 1 |
| Hayashi, H | 1 |
| Miyashita, T | 1 |
| Fushida, S | 1 |
| Ohta, T | 1 |
| Miyashita, K | 1 |
| Yasumura, R | 1 |
| Yamazaki, H | 1 |
| Kajitani, M | 1 |
| Osaki, Y | 1 |
| Kobayashi, Y | 1 |
| Chen, F | 1 |
| Zhang, J | 1 |
| Aoyama, A | 1 |
| Okamoto, T | 1 |
| Fujinaga, T | 1 |
| Bando, T | 1 |
6 other studies available for milrinone and Ischemia
| Article | Year |
|---|---|
The combined effect of zinc oxide nanoparticles and milrinone on acute renal ischemia/reperfusion injury in rats: Potential underlying mechanisms.
Topics: Acute Kidney Injury; Animals; Caspase 3; Ischemia; Lipocalin-2; Male; Milrinone; Nanoparticles; NF-E | 2023 |
Sepsis-induced digital ischaemia in a professional pianist, in the absence of vasopressors.
Topics: Adult; Amputation, Surgical; Anticoagulants; Diagnosis, Differential; Fingers; Gangrene; Heparin; Hu | 2019 |
A novel role for milrinone in neonatal acute limb ischaemia: successful conservative treatment of thrombotic arterial occlusion without thrombolysis.
Topics: Administration, Intravenous; Anticoagulants; Arm; Conservative Treatment; Female; Heparin; Humans; I | 2019 |
Pretreatment with a Phosphodiesterase-3 Inhibitor, Milrinone, Reduces Hepatic Ischemia-Reperfusion Injury, Minimizing Pericentral Zone-Based Liver and Small Intestinal Injury in Rats.
Topics: Animals; Intestine, Small; Ischemia; Ischemic Preconditioning; Liver; Male; Milrinone; Phosphodieste | 2020 |
Fatal hyperkalemia after vasodilator therapy for nonocclusive mesenteric ischemia.
Topics: Aged; Fatal Outcome; Female; Humans; Hyperkalemia; Ischemia; Mesentery; Milrinone; Potassium; Vasodi | 2014 |
Potential for pulmonary protection by nebulized milrinone during warm ischemia.
Topics: Adenine Nucleotides; Animals; Cyclic AMP; Ischemia; Lung; Male; Milrinone; Phosphodiesterase Inhibit | 2008 |